Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of EUR 157.35 billion. The enterprise value is 171.27 billion.

Market Cap	157.35B
Enterprise Value	171.27B

Important Dates

The next confirmed earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	Mar 30, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.34%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	28.21%
Float	3.18B

Valuation Ratios

The trailing PE ratio is 11.47 and the forward PE ratio is 12.65.

PE Ratio	11.47
Forward PE	12.65
PS Ratio	3.80
PB Ratio	6.06
P/TBV Ratio	18.36
P/FCF Ratio	19.93
P/OCF Ratio	9.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.26, with an EV/FCF ratio of 21.69.

EV / Earnings	12.49
EV / Sales	4.14
EV / EBITDA	8.26
EV / EBIT	9.10
EV / FCF	21.69

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.

Current Ratio	0.80
Quick Ratio	0.54
Debt / Equity	0.67
Debt / EBITDA	0.85
Debt / FCF	2.22
Interest Coverage	33.42

Financial Efficiency

Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 41.13%.

Return on Equity (ROE)	60.70%
Return on Assets (ROA)	17.43%
Return on Invested Capital (ROIC)	41.13%
Return on Capital Employed (ROCE)	42.97%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	598,447
Profits Per Employee	198,345
Employee Count	69,150
Asset Turnover	0.61
Inventory Turnover	1.20

Taxes

In the past 12 months, Novo Nordisk has paid 3.76 billion in taxes.

Income Tax	3.76B
Effective Tax Rate	21.53%

Stock Price Statistics

The stock price has decreased by -35.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-35.54%
50-Day Moving Average	33.37
200-Day Moving Average	43.03
Relative Strength Index (RSI)	59.87
Average Volume (20 Days)	2,363

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of EUR 41.38 billion and earned 13.72 billion in profits. Earnings per share was 3.08.

Revenue	41.38B
Gross Profit	34.10B
Operating Income	18.83B
Pretax Income	17.48B
Net Income	13.72B
EBITDA	20.53B
EBIT	18.83B
Earnings Per Share (EPS)	3.08

Balance Sheet

The company has 3.61 billion in cash and 17.53 billion in debt, giving a net cash position of -13.92 billion.

Cash & Cash Equivalents	3.61B
Total Debt	17.53B
Net Cash	-13.92B
Net Cash Per Share	n/a
Equity (Book Value)	25.98B
Book Value Per Share	5.85
Working Capital	-5.79B

Cash Flow

In the last 12 months, operating cash flow was 15.95 billion and capital expenditures -8.05 billion, giving a free cash flow of 7.89 billion.

Operating Cash Flow	15.95B
Capital Expenditures	-8.05B
Depreciation & Amortization	1.70B
Net Borrowing	3.31B
Free Cash Flow	7.89B
FCF Per Share	n/a

Margins

Gross margin is 82.41%, with operating and profit margins of 45.50% and 33.14%.

Gross Margin	82.41%
Operating Margin	45.50%
Pretax Margin	42.24%
Profit Margin	33.14%
EBITDA Margin	49.60%
EBIT Margin	45.50%
FCF Margin	19.08%

Dividends & Yields

This stock pays an annual dividend of 1.11, which amounts to a dividend yield of 3.18%.

Dividend Per Share	1.11
Dividend Yield	3.18%
Dividend Growth (YoY)	2.19%
Years of Dividend Growth	8
Payout Ratio	50.53%
Buyback Yield	0.34%
Shareholder Yield	3.52%
Earnings Yield	8.72%
FCF Yield	5.02%

Dividend Details

Stock Splits

The last stock split was on September 20, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 20, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 5.15 and a Piotroski F-Score of 5.

Altman Z-Score	5.15
Piotroski F-Score	5